InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,475.09
(
0.27%
)
US TECH 100
19,250.80
(
0.45%
)
Dow Jones
39,169.52
(
0.13%
)
Brent Oil
86.71
(
0.20%
)
Bitcoin
62,718.85
(
-0.21%
)
Post# of 252455
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 832
Posts 119964
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: corky post# 107138

Thursday, 11/04/2010 1:24:36 AM

Thursday, November 04, 2010 1:24:36 AM

Post# of 252455
Taribavirin, a prodrug of ribavirin that has a long history of going nowhere, is now owned by Sam Waksal’s company, Kadmon Pharmaceuticals:

http://www.reuters.com/article/idCAN0113368920101101

VRX was willing to part with this gem for $5M up-front and an 8-12% royalty on sales (that will probably never occur). I wonder what Sam is smoking :- )

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up